IR highlights

We are a global provider of X-ray detector solutions for medical, security, and industrial applications. Our company’s shares are listed on Nasdaq First North Growth Market Finland under the ticker symbol DETEC.

Latest releases

• Company Announcements

Detection Technology’s financial calendar for 2023

Next IR event

Business review January–September 2022 at 9:00 (EET)

Annual
review
2021

Explore online ›

Annual general meeting 2022

The Annual general meeting of Detection Technology Plc was held on 30 March 2022. Read more ›

Resolutions and documents

We offer off-the-shelf and customized X-ray imaging solutions for original equipment manufacturers (OEMs) and system integrators. Our solutions meet the performance and reliability requirements of the most stringent applications, such as high-end computed tomography (CT) systems. Over two billion inspections are done daily with our technology, and the number is growing rapidly.

Key figures

90 M€

Total net sales in 2021

12%

EBIT-% in 2021

370

Active customers in over 40 countries

450

Employees in Finland, China, France and the US

Global trends as growth drivers

Ageing populations
boost investments in healthcare.

The growing importance of security
boosts public and private sector investments in security.

The eco economy
boosts X-ray demand as green products and service models become more common.

The circular economy
boosts X-ray demand as recycling and material sorting increase.

Digitalization and AI
boost X-ray usability as data utilization reaches a new level.

Quality and efficiency requirements
boost the use of X-rays in quality assurance of materials, components, and processes.

Emerging markets
boost investments in healthcare and security as purchasing power increases with GDP growth.

Pandemics
boost healthcare investments in developed and emerging countries.

Lack of raw materials
boosts the use of X-rays in the exploitation of scarce discoveries.

Financial targets

MEDIUM-TERM TARGET

Annual
sales growth

10%

MEDIUM-TERM TARGET

Operating
margin

15%

ANNUAL

Dividend or
returned capital

30%

Market outlook

MEDICAL MARKET

Annual
Growth Rate

5%

SECURITY MARKET

Annual
Growth Rate

6%

INDUSTRIAL MARKET

Annual
Growth Rate

5%

Investor contacts

investors@nulldeetee.com

 

Hannu Martola

President and CEO
+358 500 449 475
hannu.martola@nulldeetee.com

For investor meetings and requests

Johanna Tarkiainen

Director, Marketing and Communications
+358 40 7287 163
johanna.tarkiainen@nulldeetee.com